PPIF Knockout THLE-2 Cell Line
Cat.No.:
EDC07850
Species:
Human
Cell Name:
THLE-2
Gene:
PPIF
Gene ID:
10105
Size:
1×10⁶cells
PPIF Knockout THLE-2 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07850 |
|---|---|
| Product Name | PPIF Knockout THLE-2 Cell Line |
| Species | Human |
| Cell Line | THLE-2 |
| Cellosaurus ID | CVCL_3803 |
| Cell Line Synonyms | THLE2, Transformed Human Liver Epithelial-2 |
| Gene ID | |
| Gene | PPIF |
| Summary |
The protein encoded by this gene is a member of the peptidyl-prolyl cis-trans isomerase (PPIase) family. PPIases catalyze the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and accelerate the folding of proteins. This protein is part of the mitochondrial permeability transition pore in the inner mitochondrial membrane. Activation of this pore is thought to be involved in the induction of apoptotic and necrotic cell death. [provided by RefSeq, Jul 2008]
|
| Associated Diseases | Non-tumor |
| Digestion Time | 4 min |
| Morphology | Adherent |
| Passage Ratio | 1:4 |
| Complete Culture Medium | THLE-2 specialized medium (Procell: CM-0833) |
| Freezing Medium | 55% DM/F12+40% FBS+5% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: THLE-2 | STR Info (Cell bank) Cell Line: THLE-2 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | Y | X | Y |
| CSF1PO | 11 | 13 | 11 | 13 |
| D2S1338 | 17 | 23 | 17 | 23 |
| D3S1358 | 14 | 15 | 14 | 15 |
| D5S818 | 11 | 13 | 11 | 13 |
| D7S820 | 10 | 12 | 10 | 12 |
| D8S1179 | 13 | 13 | ||
| D13S317 | 8 | 12 | 8 | 12 |
| D16S539 | 11 | 13 | 11 | 13 |
| D18S51 | 13 | 16 | 13 | 16 |
| D19S433 | 14 | 14 | ||
| D21S11 | 30 | 32.2 | 30 | 32.2 |
| FGA | 22 | 24 | 22 | 24 |
| Penta D | 10 | 13 | 10 | 13 |
| Penta E | 12 | 13 | 12 | 13 |
| TH01 | 7 | 9.3 | 7 | 9.3 |
| TPOX | 8 | 11 | 8 | 11 |
| vWA | 16 | 17 | 16 | 17 |
| D6S1043 | 12 | 18 | ||
| D12S391 | 21 | 23 | ||
| D2S441 | 11 | |||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying PPIF function, PPIF Knockout THLE-2 Cell Line or PPIF overexpression THLE-2 Cell Line?
The choice depends on whether you are studying PPIF (cyclophilin D, CypD)'s role as a regulator of the mitochondrial permeability transition pore (mPTP) in human hepatic context or its functions in ischemia-reperfusion injury and metabolic stress. The Knockout line is the standard tool for asking whether CypD is required for mPTP opening in human hepatocytes — CypD sensitizes mPTP opening in response to mitochondrial Ca²⁺ overload, oxidative stress, and necrotic stimuli. Overexpression is useful for testing CypD effects on mitochondrial calcium handling.
For human hepatic mitochondrial research, the EDITGENE PPIF Knockout in THLE-2 is highly relevant — THLE-2 is an SV40-immortalized normal human liver epithelial cell line, providing a human-relevant background for CypD-mPTP biology distinct from the parallel Ppif Knockout in mouse AML12 (also available). Rescue with wild-type or cyclosporin A-resistant CypD enables mechanistic studies. The knockout is a critical specificity control for cyclosporin A, NIM811, and alisporivir in hepatic ischemia-reperfusion and drug-induced liver injury research.
What are the application scenarios for this model?
Primary applications:
• Human hepatic mPTP opening: calcein-cobalt retention or membrane potential assessment following Ca²⁺ challenge to assess CypD-mPTP regulation in human hepatocyte context.
• Hepatic ischemia-reperfusion modeling: anoxia/reoxygenation and oxidative stress assays in THLE-2's normal human liver epithelial background.
• Drug-induced liver injury: acetaminophen, valproate, and other hepatotoxin sensitivity studies in CypD-null human hepatocytes.
• mPTP inhibitor specificity: critical genetic control for cyclosporin A, NIM811, alisporivir in human-relevant hepatic protection research.
EDITGENE recommends this human hepatic model for hepatic mitochondrial permeability transition research; the parallel Ppif Knockout in mouse AML12 (also available) complements for species-comparative studies.
Is this PPIF Knockout THLE-2 Cell Line compatible with overexpression rescue experiments?
Yes. CypD rescue experiments require attention to mitochondrial targeting:
• Construct design: use a codon-modified PPIF sequence with a small C-terminal tag (FLAG, HA). CypD has N-terminal mitochondrial targeting sequence — N-terminal tags must not disrupt processing.
• Mitochondrial localization validation: confirm mitochondrial matrix localization before functional assays.
• Cyclosporin A-resistant rescue: specific mutations in the cyclosporin A binding pocket enable testing CsA on-target effects.
• Functional readout: rescue should restore mPTP opening sensitivity to Ca²⁺ challenge measured by mitochondrial swelling, membrane potential loss, or calcein retention assays.
THLE-2 is an SV40-immortalized normal human liver epithelial cell line — transduction with lentivirus is supported but may require optimization compared to standard transformed cell lines.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download